The Impact of Emicizumab Prophylaxis on Hospitalizations and Emergency Department Visits Among Hemophilia A Patients Is Age Related

Documenti analoghi

• Emicizumab in Previously Untreated Patients and Minimally Treated Patients With Hemophilia A: A Comparative Study Between Two International Cohorts
  di: Sarina Levy‐Mendelovich, et al.
  Pubblicazione: (2025)
• Pediatric splenic infarction: Assessment of associated clinical conditions and outcome
  di: Evgeny Grishin, et al.
  Pubblicazione: (2024)
• Emicizumab prophylaxis in infants: Single‐centre experience
  di: Sarina Levy‐Mendelovich, et al.
  Pubblicazione: (2024)
• Milds Matter—Feasibility of Emicizumab Prophylaxis in Mild Hemophilia
  di: Kyle Davis, et al.
  Pubblicazione: (2026)
• Importance of Inhibitor Surveillance During Emicizumab Prophylaxis in Young Children With Hemophilia: An Illustrative Case Series
  di: Kelly A. Bush, et al.
  Pubblicazione: (2025)